FDA Inspection 1197680 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - February 17, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, with an inspection on February 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
Inspection Date: February 17, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 977b66ca-6f39-4a4d-b230-c50aeda40300